InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. EAT

Go back to InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
INSPIREMD, Inc. (NASDAQ: NSPR) Delayed: 0.85 +0.01 (1.19%)
Previous Close $0.84    52 Week High $3.35 
Open $0.84    52 Week Low $0.07 
Day High $0.90    P/E N/A 
Day Low $0.83    EPS $-0.96 
Volume 30,331